[go: up one dir, main page]

AU8192691A - Method of treatment and compositions therefore - Google Patents

Method of treatment and compositions therefore

Info

Publication number
AU8192691A
AU8192691A AU81926/91A AU8192691A AU8192691A AU 8192691 A AU8192691 A AU 8192691A AU 81926/91 A AU81926/91 A AU 81926/91A AU 8192691 A AU8192691 A AU 8192691A AU 8192691 A AU8192691 A AU 8192691A
Authority
AU
Australia
Prior art keywords
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU81926/91A
Inventor
Anthony Raven
Christopher John Stanley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diomed Ltd
Original Assignee
Diomed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diomed Ltd filed Critical Diomed Ltd
Publication of AU8192691A publication Critical patent/AU8192691A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
AU81926/91A 1990-06-27 1991-06-27 Method of treatment and compositions therefore Abandoned AU8192691A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909014307A GB9014307D0 (en) 1990-06-27 1990-06-27 Method of treatment and compositions therefor
GB9014307 1990-06-27
PCT/GB1991/001044 WO1992000106A2 (en) 1990-06-27 1991-06-27 Method of treatment and compositions therefore

Publications (1)

Publication Number Publication Date
AU8192691A true AU8192691A (en) 1992-01-23

Family

ID=10678289

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81926/91A Abandoned AU8192691A (en) 1990-06-27 1991-06-27 Method of treatment and compositions therefore

Country Status (4)

Country Link
EP (1) EP0536211A1 (en)
AU (1) AU8192691A (en)
GB (1) GB9014307D0 (en)
WO (1) WO1992000106A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258305A (en) * 1991-09-13 1993-11-02 Nitto Chemical Industry Co., Ltd. Manufacture of optically active 2-phenylpropionic acid and 2-phenylpropionamide from the nitrile using Rhodococcus equi
US5885211A (en) * 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
ATE264694T1 (en) * 1995-01-30 2004-05-15 Daiichi Pure Chemicals Co Ltd DIAGNOSTIC MARKER
DK1563788T3 (en) 1995-08-29 2015-05-11 Nitto Denko Corp Microperforation of human skin for drug administration and monitoring purposes
JP3899427B2 (en) * 1995-08-29 2007-03-28 アルテア セラピューティクス コーポレイション Microperforation of human skin for drug delivery and inspection applications
WO1997033620A2 (en) * 1996-03-15 1997-09-18 Pulsion Verw. Gmbh & Co. Medical Systems Kg Compounds for treating tumours
US6527716B1 (en) 1997-12-30 2003-03-04 Altea Technologies, Inc. Microporation of tissue for delivery of bioactive agents
EP1056396B1 (en) * 1998-02-17 2005-11-09 Abbott Laboratories Interstitial fluid collection and monitoring device
US6602274B1 (en) 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
US6454789B1 (en) 1999-01-15 2002-09-24 Light Science Corporation Patient portable device for photodynamic therapy
CA2356532A1 (en) 1999-01-15 2000-07-20 Light Sciences Corporation Noninvasive vascular therapy
US20030078499A1 (en) 1999-08-12 2003-04-24 Eppstein Jonathan A. Microporation of tissue for delivery of bioactive agents
EP1267935A2 (en) 2000-01-12 2003-01-02 Light Sciences Corporation Novel treatment for eye disease
US9918665B2 (en) 2002-03-11 2018-03-20 Nitto Denko Corporation Transdermal porator and patch system and method for using same
US7392080B2 (en) 2002-03-11 2008-06-24 Altea Therapeutics Corporation Transdermal drug delivery patch system, method of making same and method of using same
US8016811B2 (en) 2003-10-24 2011-09-13 Altea Therapeutics Corporation Method for transdermal delivery of permeant substances

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806488A (en) * 1985-09-06 1989-02-21 Syntex (U.S.A.) Inc. Ligand-receptor assays employing squarate dye compositions
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
HU204856B (en) * 1987-08-12 1992-02-28 Orszagos Mueszaki Fejlesztesi Process for releasing cell mixtures and tissues from undesired populations and for producing monoclonal antibody - hematoporphyrin conjugates
DE3828360A1 (en) * 1988-08-20 1990-02-22 Stanowsky Alexander Dr DYE-MARKED ANTITUMOR ANTIBODY AND METHOD FOR THE PRODUCTION THEREOF
AU641658B2 (en) * 1989-06-07 1993-09-30 University Of British Columbia, The Photosensitizing diels-alder porphyrin derivatives

Also Published As

Publication number Publication date
EP0536211A1 (en) 1993-04-14
WO1992000106A3 (en) 1992-02-20
WO1992000106A2 (en) 1992-01-09
GB9014307D0 (en) 1990-08-15

Similar Documents

Publication Publication Date Title
AU4032989A (en) Method and compositions for the treatment and prevention of septic shock
AU4028995A (en) Antitumor compositions and methods of treatment
AU4214193A (en) Bioadhesive treatment compositions and method of use
AU5287090A (en) Method and composition for treatment of periodontal disease
AU7780391A (en) Low level blasting composition and method of blasting same
AU8044491A (en) Antitumor compositions and methods of treatment
AU8653091A (en) Crystallizing enamel composition and method of using the same
AU8192691A (en) Method of treatment and compositions therefore
AU2114792A (en) Win 49596-finasteride method of use and compositions
AU3406893A (en) Method and composition for the treatment of osteoporosis
GB9027968D0 (en) Method of treatment
AU4520893A (en) Sterilization process and composition
AU1919592A (en) Method of treating trichotillomania and onychophagia
AU8427091A (en) Gamma-carboxylase and methods of use
AU2685892A (en) Method of treating blood
AU7770991A (en) Method and composition for the treatment of cancer
AU4104093A (en) Method and compositions for treatment of pyonecrotic processes
AU7366591A (en) Method and composition for water treatment
AU8113091A (en) Method of treatment of allergic conjunctivitis
CS61691A2 (en) Composition for dung-water treatment and method of dung-water treatment
PL303822A1 (en) Therapeutic compositions containing ipsapyrone and method of obtaining them
AU8266691A (en) Method of disinfection
HK1007936B (en) Method of disinfection
AU4652393A (en) Plant treating composition and methods of making and using same
AU8819691A (en) Treatment of gas